Study of Pharmacotherapy of Psychotic Depression

Completed · Phase 3 · Has a placebo group

Conditions studied: Major Depressive Disorder With Psychotic Features

In brief

This study will determine the effectiveness of combining selective serotonin reuptake inhibitors (SSRIs) with antipsychotic medications in the treatment of psychotic depression.

Key facts

Study ID

NCT00056472

Run by

Weill Medical College of Cornell University

People needed

259

Starts

2003-01-01

Expected to finish

2008-06-01

Last updated by the study team

2013-08-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Major depressive disorder, single or recurrent, with psychotic features

You may not qualify if…

• History of substance abuse or dependence within the 3 months prior to enrollment
• Acute or unstable medical illness
• Diagnosis of schizophrenia or other psychotic disorders
• Pregnant
• Intolerance to SSRIs or olanzapine

Where it is running

• University of Massachusetts Medical School — Worcester, Massachusetts, United States
• Cornell University — New York, New York, United States
• University of Pittsburgh — Pittsburgh, Pennsylvania, United States
• University of Toronto — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.